Scotts Miracle Gro Q2 2024 Adj EPS $3.69 Beats $3.40 Estimate, Sales $1.38B Miss $1.50B Estimate
Portfolio Pulse from Benzinga Newsdesk
Scotts Miracle Gro (SMG) reported Q2 2024 adjusted EPS of $3.69, surpassing the $3.40 estimate, but its sales of $1.38B fell short of the $1.50B estimate, marking a 9.92% decrease from the previous year.

May 01, 2024 | 11:04 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Scotts Miracle Gro reported higher-than-expected Q2 2024 EPS but missed sales estimates, with a significant year-over-year decrease.
While the EPS beat may positively impact investor sentiment towards SMG, the miss on sales estimates and the significant year-over-year decrease could temper any potential stock price gains. The mixed results present a neutral outlook in the short term as investors weigh the better-than-expected earnings against the sales miss and year-over-year decline.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100